(Q45675191)

English

Effect of partial and complete variable loop deletions of the human immunodeficiency virus type 1 envelope glycoprotein on the breadth of gp160-specific immune responses

scientific article published in January 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 December 2017

Effect of partial and complete variable loop deletions of the human immunodeficiency virus type 1 envelope glycoprotein on the breadth of gp160-specific immune responses (English)

1 reference

Europe PubMed Central

15 December 2017

author name string

Jaroslaw Gzyl

1

1 reference

Europe PubMed Central

15 December 2017

Elizabeth Bolesta

2

1 reference

Europe PubMed Central

15 December 2017

Andrew Wierzbicki

3

1 reference

Europe PubMed Central

15 December 2017

Dariusz Kmieciak

4

1 reference

Europe PubMed Central

15 December 2017

Toshio Naito

5

1 reference

Europe PubMed Central

15 December 2017

Mitsuo Honda

6

1 reference

Europe PubMed Central

15 December 2017

Katsutoshi Komuro

7

1 reference

Europe PubMed Central

15 December 2017

Yutaro Kaneko

8

1 reference

Europe PubMed Central

15 December 2017

Danuta Kozbor

9

1 reference

Europe PubMed Central

15 December 2017

language of work or name

0 references

publication date

1 January 2004

1 reference

Europe PubMed Central

15 December 2017

1 reference

Europe PubMed Central

15 December 2017

318

1 reference

Europe PubMed Central

15 December 2017

2

1 reference

Europe PubMed Central

15 December 2017

493-506

1 reference

Europe PubMed Central

15 December 2017

The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

Identification of conserved and variable structures in the human immunodeficiency virus gp120 glycoprotein of importance for CXCR4 binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

Generation of Human Monoclonal Antibodies against HIV-1 Proteins; Electrofusion and Epstein-Barr Virus Transformation for Peripheral Blood Lymphocyte Immortalization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

Polyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous Simian/human immunodeficiency virus infection in pigtailed macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

Protection of SIVmac-infected macaque monkeys against superinfection by a simian immunodeficiency virus expressing envelope glycoproteins of HIV type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

Mucosal and systemic immune responses induced after oral delivery of vaccinia virus recombinants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

Immunogenicity and ability of variable loop-deleted human immunodeficiency virus type 1 envelope glycoproteins to elicit neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

Effect of the V3 loop deletion of envelope glycoprotein on cellular responses and protection against challenge with recombinant vaccinia virus expressing gp160 of primary human immunodeficiency virus type 1 isolates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

Immunogenicity of DNA vaccines expressing human immunodeficiency virus type 1 envelope glycoprotein with and without deletions in the V1/2 and V3 regions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

The N-terminal V3 loop glycan modulates the interaction of clade A and B human immunodeficiency virus type 1 envelopes with CD4 and chemokine receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

HIV. Envelope's letters boxed into shape.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

Immunoreactivity of intact virions of human immunodeficiency virus type 1 (HIV-1) reveals the existence of fewer HIV-1 immunotypes than genotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

A global neutralization resistance phenotype of human immunodeficiency virus type 1 is determined by distinct mechanisms mediating enhanced infectivity and conformational change of the envelope complex

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

Fine definition of the epitope on the gp41 glycoprotein of human immunodeficiency virus type 1 for the neutralizing monoclonal antibody 2F5.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

Early HIV-1 envelope-specific cytotoxic T lymphocyte responses in vertically infected infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

A role for carbohydrates in immune evasion in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

The ability of HIV type 1 to use CCR-3 as a coreceptor is controlled by envelope V1/V2 sequences acting in conjunction with a CCR-5 tropic V3 loop

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

Oligomeric and conformational properties of a proteolytically mature, disulfide-stabilized human immunodeficiency virus type 1 gp140 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

Changes in the immunogenic properties of soluble gp140 human immunodeficiency virus envelope constructs upon partial deletion of the second hypervariable region

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

Immunization strategies to augment oral vaccination with DNA and viral vectors expressing HIV envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

The antigenic structure of the HIV gp120 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

based on heuristic

inferred from DOI database lookup

Neutralization of primary human immunodeficiency virus type 1 isolates by the broadly reactive anti-V3 monoclonal antibody, 447-52D

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

based on heuristic

inferred from DOI database lookup

An envelope modification that renders a primary, neutralization-resistant clade B human immunodeficiency virus type 1 isolate highly susceptible to neutralization by sera from other clades.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

based on heuristic

inferred from DOI database lookup

Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

based on heuristic

inferred from DOI database lookup

Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

based on heuristic

inferred from DOI database lookup

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.009

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2003.10.009

1 reference

Europe PubMed Central

15 December 2017

1 reference

Europe PubMed Central

15 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45675191&oldid=2077465204"